Table 1.

Final results for the DE group

		ANOVA Table
			Sum of Squares	df	Mean Square	F	Sig.
TBUT RE* Oncology	Between Groups	(Combined)	,235	1	,235	,017	,897
	Within Groups		430,310	31	13,881
	Total		430,545	32
TBUT LE* Oncology	Between Groups	(Combined)	17,120	1	17,120	1,605	,215
	Within Groups		330,759	31	10,670
	Total		347,879	32
Lactoferrin RE* Oncology	Between Groups	(Combined)	16,080	1	16,080	,954	,336
	Within Groups		522,362	31	16,850
	Total		538,442	32
Lactoferrin LE* Oncology	Between Groups	(Combined)	86,370	1	86,370	3,995	,054
	Within Groups		670,129	31	21,617
	Total		756,499	32
Lyzozyme RE* Oncology	Between Groups	(Combined)	39,571	1	39,571	2,026	,165
	Within Groups		605,352	31	19,527
	Total		644,922	32
Lyzozyme LE* Oncology	Between Groups	(Combined)	370,367	1	370,367	9,605	,004
	Within Groups		1195,414	31	38,562
	Total		1565,782	32
Lipocalin RE* Oncology	Between Groups	(Combined)	23,968	1	23,968	,527	,473
	Within Groups		1409,822	31	45,478
	Total		1433,790	32
Lipocalin LE* Oncology	Between Groups	(Combined)	38,200	1	38,200	1,041	,316
	Within Groups		1137,890	31	36,706
	Total		1176,090	32